Financhill
Back

Acumen Pharmaceuticals Quote, Financials, Valuation and Earnings

Acumen Pharmaceuticals Price Quote

$3.15
-0.01 (-0.32%)
(Updated: April 19, 2024 at 6:55 PM ET)

Acumen Pharmaceuticals Key Stats

Sell
27
Acumen Pharmaceuticals (ABOS) is a Sell

Day range:
$3.11 - $3.48
52-week range:
$1.81 - $11.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.71%

Volume:
626.5K
Avg. volume:
313K
1-year change:
-11.98%
Market cap:
$189.9M
Revenue:
$0
EPS:
$-1.09

How Much Does Acumen Pharmaceuticals Make?

Data Unavailable

Is Acumen Pharmaceuticals Growing As A Company?

Data Unavailable

Acumen Pharmaceuticals Stock Price Performance

What Is Acumen Pharmaceuticals 52-Week High & Low?

Acumen Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Acumen Pharmaceuticals?

Is Acumen Pharmaceuticals Cash Flow Positive?

  • What Is ABOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$43.1M
  • What Is Acumen Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Acumen Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$171.7M

Acumen Pharmaceuticals Return On Invested Capital

Data Unavailable

Acumen Pharmaceuticals Earnings Date & Stock Price

Acumen Pharmaceuticals Competitors

Acumen Pharmaceuticals Dividend Yield

Data Unavailable

Acumen Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -15.64%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.80
Upside from Last Price: 305.06%

Major Shareholders

  • How many ABOS shares are owned by institutional investors?
    61.3M ABOS shares are owned by institutional investors
  • How many ABOS shares are owned by insiders?
    1.2M ABOS shares are owned by insiders